Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycemic control in hospitalized type 2 diabetes mellitus: Thammasart insulin protocol vs routine care
TCTR20180316006Not yet recruiting
- Start
- Apr 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by None. Planned start Apr 2018; status: not yet recruiting.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20180316006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180316006.